Could a simple pill keep relapsed testicular cancer at bay?

NCT ID NCT04804007

Recruiting now Disease control Sponsor: Nabil Adra Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for people with relapsed germ cell tumors (a type of cancer often in the testicles or ovaries) who have already had high-dose chemotherapy and a stem cell transplant. It tests whether taking a daily oral chemotherapy drug called etoposide for a while after treatment can help keep the cancer from coming back, compared to just watching and waiting. The trial will enroll 64 adults and track cancer progression and side effects over 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

germ cell tumor Neoplasms, Germ Cell and Embryonal nongerminomatous germ cell tumor Nonseminomatous germ cell tumor ovarian germ cell tumor testicular non-seminomatous germ cell tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERM CELL TUMOR NON-SEMINOMATOUS GERM CELL TUMOR OVARIAN GERM CELL TUMOR

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Indiana University Melvin & Bren Simon Cancer Center
RECRUITING

Indianapolis, Indiana, 46202, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact